Susan Sullivan

Susan Sullivan is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as Executive Director of Program and Alliance Management at Iksuda Therapeutics since July 2018. With a career spanning over three decades, Susan has held various leadership roles, including VP Operations at Verik Bio and Senior Director of Alliance Management at ImmunoGen, Inc., where management of portfolio Alliance programs led to ten products entering clinical trials for targeted oncology therapies. Susan co-founded Amaranth Bio, focusing on cell therapy technologies for diabetes and liver disease, and has significant experience in research and development from previous positions at Organogenesis, One Cell Systems, BioHybrid Technologies, and as a Postdoctoral Fellow at Harvard School of Public Health. Educational credentials include a Ph.D. in Cell Biology from the University of Pennsylvania and a B.S. in Biology from Tufts University.